142 related articles for article (PubMed ID: 16733863)
21. Adenocarcinoma of gallbladder: an immunohistochemical profile and comparison with cholangiocarcinoma.
Hughes NR; Bhathal PS
J Clin Pathol; 2013 Mar; 66(3):212-7. PubMed ID: 23268317
[TBL] [Abstract][Full Text] [Related]
22. p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas.
Walker C; Robertson LJ; Myskow MW; Pendleton N; Dixon GR
Br J Cancer; 1994 Aug; 70(2):297-303. PubMed ID: 7914423
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.
Morris CD; Armstrong GR; Bigley G; Green H; Attwood SE
Am J Gastroenterol; 2001 Apr; 96(4):990-6. PubMed ID: 11316217
[TBL] [Abstract][Full Text] [Related]
24. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
[TBL] [Abstract][Full Text] [Related]
25. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT
Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
[TBL] [Abstract][Full Text] [Related]
26. p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma.
Harpaz N; Peck AL; Yin J; Fiel I; Hontanosas M; Tong TR; Laurin JN; Abraham JM; Greenwald BD; Meltzer SJ
Hum Pathol; 1994 Oct; 25(10):1069-74. PubMed ID: 7927312
[TBL] [Abstract][Full Text] [Related]
27. p53 tumour suppressor gene protein expression in early and advanced gallbladder carcinoma.
Roa I; Villaseca M; Araya J; Roa J; de Aretxabala X; Melo A; Ibacache G
Histopathology; 1997 Sep; 31(3):226-30. PubMed ID: 9354892
[TBL] [Abstract][Full Text] [Related]
28. Reduced p21(WAF1/CIP1) expression is an early event in gallbladder carcinogenesis and is of prognostic significance for patients with carcinomas of the gallbladder.
Li X; Hui AM; Shi YZ; Takayama T; Makuuchi M
Hum Pathol; 2001 Aug; 32(8):771-7. PubMed ID: 11521218
[TBL] [Abstract][Full Text] [Related]
29. [Precancerous states of the larynx: analysis of mono- and polyclonality of the cells with high proliferative index (p53, PCNA)].
Gabriel A; Namysłowski G; Drozdzowska B; Morawski K; Steplewska-Mazur K; Gwóźdź M
Otolaryngol Pol; 2000; 54 Suppl 31():178-81. PubMed ID: 10974878
[TBL] [Abstract][Full Text] [Related]
30. Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53.
Feith M; Stein HJ; Mueller J; Siewert JR
Dis Esophagus; 2004; 17(4):322-7. PubMed ID: 15569371
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of cyclooxygenase-2 expression and nuclear p53 accumulation in patients with colorectal cancer.
Lim SC; Lee TB; Choi CH; Ryu SY; Min YD; Kim KJ
J Surg Oncol; 2008 Jan; 97(1):51-6. PubMed ID: 17929263
[TBL] [Abstract][Full Text] [Related]
32. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
[TBL] [Abstract][Full Text] [Related]
33. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus.
Shamma A; Yamamoto H; Doki Y; Okami J; Kondo M; Fujiwara Y; Yano M; Inoue M; Matsuura N; Shiozaki H; Monden M
Clin Cancer Res; 2000 Apr; 6(4):1229-38. PubMed ID: 10778945
[TBL] [Abstract][Full Text] [Related]
35. Cyclooxygenase-2 expression in the gallbladder of patients with anomalous arrangement of the pancreaticobiliary duct.
Fumino S; Tokiwa K; Ono S; Iwai N
J Pediatr Surg; 2003 Apr; 38(4):585-9. PubMed ID: 12677571
[TBL] [Abstract][Full Text] [Related]
36. DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma.
Roa I; Villaseca M; Araya JC; Roa J; de Aretxabala X; Fuentealba P; Melo A
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):547-50. PubMed ID: 9232344
[TBL] [Abstract][Full Text] [Related]
37. Molecular comparison of concurrent components of high-grade dysplasia, adenocarcinoma, and sarcomatoid carcinoma in a case of sarcomatoid carcinoma of the gallbladder.
Hirose K; Omori Y; Ono Y; Mizukami Y; Kaneko Y; Maruyama T; Ohtani H; Furukawa T
Virchows Arch; 2023 Aug; 483(2):261-266. PubMed ID: 36892636
[TBL] [Abstract][Full Text] [Related]
38. Expression of the p16(INK4a) gene product in premalignant and malignant epithelial lesions of the gallbladder.
Lynch BC; Lathrop SL; Ye D; Ma TY; Cerilli LA
Ann Diagn Pathol; 2008 Jun; 12(3):161-4. PubMed ID: 18486890
[TBL] [Abstract][Full Text] [Related]
39. The value of thioredoxin family proteins and proliferation markers in dysplastic and malignant gallbladders in patients with primary sclerosing cholangitis.
Said K; Glaumann H; Björnstedt M; Bergquist A
Dig Dis Sci; 2012 May; 57(5):1163-70. PubMed ID: 22370917
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
